Drug intelligence / Profile preview

Ikaros shRNA

Development stage
Preclinical
Lead developer
The Pennsylvania State University
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Parenteral
01

Overview

Ikaros shRNA is a short hairpin RNA (shRNA) construct designed to silence the expression of the Ikaros transcription factor, which is encoded by the *IKZF1* gene. Ikaros is a critical tumor suppressor protein in lymphoid cells, and its loss or inactivation is a hallmark of T-cell acute lymphoblastic leukemia (T-ALL). In research settings, Ikaros shRNA is utilized to model Ikaros deficiency, demonstrating that its knockdown leads to the upregulation of oncogenic targets such as CDC25a, which promotes cell cycle progression. This tool is primarily used in preclinical studies to elucidate the regulatory networks involving Casein Kinase II (CK2) and Ikaros in leukemogenesis, providing a rationale for therapeutic strategies that restore Ikaros activity or inhibit its upstream regulators.

Other names
IKZF1 shRNAIKZF-1 shRNAIKZF 1 shRNAIkaros short hairpin RNA
02

Targets

IKZF1 (Ikaros family zinc finger protein 1)

Beyond the preview

Go deeper on Ikaros shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ikaros shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call